These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35234810)

  • 1. Finding Pulmonary Arterial Hypertension-Switching to Offense to Mitigate Disease Burden.
    Maron BA; Humbert M
    JAMA Cardiol; 2022 Apr; 7(4):369-370. PubMed ID: 35234810
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary Arterial Hypertension and Specialty Care Centers: We Had a Feeling; Now We Have Data.
    Chakinala MM; Farber HW
    Chest; 2020 Jul; 158(1):28-30. PubMed ID: 32654707
    [No Abstract]   [Full Text] [Related]  

  • 3. The Evolution of Risk Assessment in Pulmonary Arterial Hypertension.
    Murthy S; Benza R
    Methodist Debakey Cardiovasc J; 2021; 17(2):134-144. PubMed ID: 34326933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of the Myelodysplastic Syndrome as a Cause of Group 5 Pulmonary Arterial Hypertension: An Orphan Disease in an Orphan Pulmonary Hypertension Group.
    Carrillo-Rocha DL; Roldan-Valadez E; Cueto-Robledo G; Garcia-Cesar M; Cueto-Romero HD
    Curr Probl Cardiol; 2023 May; 48(5):101110. PubMed ID: 35007638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Finding the needle in the haystack: BMP9 and 10 emerge from the genome in pulmonary arterial hypertension.
    Morrell NW
    Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30872557
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pulmonary arterial hypertension: achievements and realities of modern treatment, a look into the future].
    Martynyuk TV; Chazova IE
    Ter Arkh; 2021 Sep; 93(9):1009-1017. PubMed ID: 36286859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical application of pulmonary vascular resistance in patients with pulmonary arterial hypertension.
    Deng J
    J Cardiothorac Surg; 2021 Oct; 16(1):311. PubMed ID: 34670595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary Hypertension: A Contemporary Review.
    Johnson S; Sommer N; Cox-Flaherty K; Weissmann N; Ventetuolo CE; Maron BA
    Am J Respir Crit Care Med; 2023 Sep; 208(5):528-548. PubMed ID: 37450768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multilevel omics: A next step on the way to understanding pulmonary arterial hypertension?
    Aman J; Hovingh GK
    Thorax; 2019 Apr; 74(4):317-318. PubMed ID: 30679265
    [No Abstract]   [Full Text] [Related]  

  • 10. Associations of Histamine Metabolites with Disease Severity and Mortality in Pulmonary Arterial Hypertension.
    Peplinski BS; Buber J; Gharib SA; Pi H; Raftery D; Leary PJ
    Ann Am Thorac Soc; 2023 Nov; 20(11):1676-1679. PubMed ID: 37668470
    [No Abstract]   [Full Text] [Related]  

  • 11. The Pathobiology of Pulmonary Arterial Hypertension.
    Rajagopal S; Yu YA
    Cardiol Clin; 2022 Feb; 40(1):1-12. PubMed ID: 34809910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deconstructing the Melting Pot in Pulmonary Arterial Hypertension.
    Austin ED; Hamid R
    Am J Respir Crit Care Med; 2020 Jun; 201(11):1329-1331. PubMed ID: 32053755
    [No Abstract]   [Full Text] [Related]  

  • 13. Decoding the Link Between Inflammation and Pulmonary Arterial Hypertension.
    Zhong Y; Yu PB
    Circulation; 2022 Sep; 146(13):1023-1025. PubMed ID: 36154621
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessing the cancer hypothesis of pulmonary arterial hypertension: the devil is in the detail.
    Frump AL; Lai YC; Lahm T
    Am J Physiol Lung Cell Mol Physiol; 2020 Jun; 318(6):L1140-L1141. PubMed ID: 32186392
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk scores as a surrogate in pulmonary arterial hypertension: a different lens - Authors' reply.
    Harhay MO; Blette BS; Kawut SM
    Lancet Respir Med; 2024 Mar; 12(3):e11. PubMed ID: 38423703
    [No Abstract]   [Full Text] [Related]  

  • 16. ECMO in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension as a bridge to therapy.
    Cruz-Utrilla A; García-Martín EP; Domínguez Pérez L; Ruiz Curiel A; Quezada A; Durante López A; Vicent L; Martín Asenjo R; Hinojosa W; Eixerés A; Forcén Acebal L; Galindo M; Arribas Ynsaurriaga F; Escribano-Subias P; Bueno H
    Kardiol Pol; 2023; 81(5):500-504. PubMed ID: 36871299
    [No Abstract]   [Full Text] [Related]  

  • 17. The cancer hypothesis of pulmonary arterial hypertension: the next ten years.
    Condon D; Agarwal S; Chakraborty A; de Jesus Perez VA
    Am J Physiol Lung Cell Mol Physiol; 2020 Jun; 318(6):L1138-L1139. PubMed ID: 32186209
    [No Abstract]   [Full Text] [Related]  

  • 18. Adding an important piece to the pulmonary vascular resistance puzzle in pulmonary arterial hypertension.
    Maron BA; Humbert M
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32646896
    [No Abstract]   [Full Text] [Related]  

  • 19. Checkpoint Kinase 1 Promotes the Development of Pulmonary Arterial Hypertension.
    Satoh K; Kikuchi N; Kurosawa R; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2019 Aug; 39(8):1504-1506. PubMed ID: 31339778
    [No Abstract]   [Full Text] [Related]  

  • 20. "Rehab for all!" Is it too early in pulmonary arterial hypertension?
    Bertoletti L; Bouvaist H; Tromeur C; Bezzeghoud S; Dauphin C; Enache I; Bourdin A; Seronde MF; Montani D; Turquier S; Pison C; ;
    Eur Respir J; 2019 Nov; 54(5):. PubMed ID: 31699779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.